BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28190459)

  • 1. Mutations in INPP5K Cause a Form of Congenital Muscular Dystrophy Overlapping Marinesco-Sjögren Syndrome and Dystroglycanopathy.
    Osborn DPS; Pond HL; Mazaheri N; Dejardin J; Munn CJ; Mushref K; Cauley ES; Moroni I; Pasanisi MB; Sellars EA; Hill RS; Partlow JN; Willaert RK; Bharj J; Malamiri RA; Galehdari H; Shariati G; Maroofian R; Mora M; Swan LE; Voit T; Conti FJ; Jamshidi Y; Manzini MC
    Am J Hum Genet; 2017 Mar; 100(3):537-545. PubMed ID: 28190459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in INPP5K, Encoding a Phosphoinositide 5-Phosphatase, Cause Congenital Muscular Dystrophy with Cataracts and Mild Cognitive Impairment.
    Wiessner M; Roos A; Munn CJ; Viswanathan R; Whyte T; Cox D; Schoser B; Sewry C; Roper H; Phadke R; Marini Bettolo C; Barresi R; Charlton R; Bönnemann CG; Abath Neto O; Reed UC; Zanoteli E; Araújo Martins Moreno C; Ertl-Wagner B; Stucka R; De Goede C; Borges da Silva T; Hathazi D; Dell'Aica M; Zahedi RP; Thiele S; Müller J; Kingston H; Müller S; Curtis E; Walter MC; Strom TM; Straub V; Bushby K; Muntoni F; Swan LE; Lochmüller H; Senderek J
    Am J Hum Genet; 2017 Mar; 100(3):523-536. PubMed ID: 28190456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INPP5K variant causes autosomal recessive congenital cataract in a Pakistani family.
    Yousaf S; Sheikh SA; Riazuddin S; Waryah AM; Ahmed ZM
    Clin Genet; 2018 Mar; 93(3):682-686. PubMed ID: 28940338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INPP5K and SIL1 associated pathologies with overlapping clinical phenotypes converge through dysregulation of PHGDH.
    Hathazi D; Cox D; D'Amico A; Tasca G; Charlton R; Carlier RY; Baumann J; Kollipara L; Zahedi RP; Feldmann I; Deleuze JF; Torella A; Cohn R; Robinson E; Ricci F; Jungbluth H; Fattori F; Boland A; O'Connor E; Horvath R; Barresi R; Lochmüller H; Urtizberea A; Jacquemont ML; Nelson I; Swan L; Bonne G; Roos A
    Brain; 2021 Sep; 144(8):2427-2442. PubMed ID: 33792664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of INPP5K compromises the differentiation of N2A cells.
    Manzolillo A; Gresing L; Hübner CA; Franzka P
    Front Mol Neurosci; 2024; 17():1356343. PubMed ID: 38559586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation.
    Puckett RL; Moore SA; Winder TL; Willer T; Romansky SG; Covault KK; Campbell KP; Abdenur JE
    Neuromuscul Disord; 2009 May; 19(5):352-6. PubMed ID: 19342235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIL1 mutations and clinical spectrum in patients with Marinesco-Sjogren syndrome.
    Krieger M; Roos A; Stendel C; Claeys KG; Sonmez FM; Baudis M; Bauer P; Bornemann A; de Goede C; Dufke A; Finkel RS; Goebel HH; Häussler M; Kingston H; Kirschner J; Medne L; Muschke P; Rivier F; Rudnik-Schöneborn S; Spengler S; Inzana F; Stanzial F; Benedicenti F; Synofzik M; Lia Taratuto A; Pirra L; Tay SK; Topaloglu H; Uyanik G; Wand D; Williams D; Zerres K; Weis J; Senderek J
    Brain; 2013 Dec; 136(Pt 12):3634-44. PubMed ID: 24176978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole exome sequencing identified a novel DAG1 mutation in a patient with rare, mild and late age of onset muscular dystrophy-dystroglycanopathy.
    Dai Y; Liang S; Dong X; Zhao Y; Ren H; Guan Y; Yin H; Li C; Chen L; Cui L; Banerjee S
    J Cell Mol Med; 2019 Feb; 23(2):811-818. PubMed ID: 30450679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies.
    Cirak S; Foley AR; Herrmann R; Willer T; Yau S; Stevens E; Torelli S; Brodd L; Kamynina A; Vondracek P; Roper H; Longman C; Korinthenberg R; Marrosu G; Nürnberg P; ; Michele DE; Plagnol V; Hurles M; Moore SA; Sewry CA; Campbell KP; Voit T; Muntoni F
    Brain; 2013 Jan; 136(Pt 1):269-81. PubMed ID: 23288328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Recurrent Pathogenic Variant of
    D'Amico A; Fattori F; Nicita F; Barresi S; Tasca G; Verardo M; Pizzi S; Moroni I; De Mitri F; Frongia A; Pane M; Mercuri E; Tartaglia M; Bertini E
    Front Genet; 2020; 11():565868. PubMed ID: 33193651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.
    Stevens E; Carss KJ; Cirak S; Foley AR; Torelli S; Willer T; Tambunan DE; Yau S; Brodd L; Sewry CA; Feng L; Haliloglu G; Orhan D; Dobyns WB; Enns GM; Manning M; Krause A; Salih MA; Walsh CA; Hurles M; Campbell KP; Manzini MC; ; Stemple D; Lin YY; Muntoni F
    Am J Hum Genet; 2013 Mar; 92(3):354-65. PubMed ID: 23453667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan.
    Carss KJ; Stevens E; Foley AR; Cirak S; Riemersma M; Torelli S; Hoischen A; Willer T; van Scherpenzeel M; Moore SA; Messina S; Bertini E; Bönnemann CG; Abdenur JE; Grosmann CM; Kesari A; Punetha J; Quinlivan R; Waddell LB; Young HK; Wraige E; Yau S; Brodd L; Feng L; Sewry C; MacArthur DG; North KN; Hoffman E; Stemple DL; Hurles ME; van Bokhoven H; Campbell KP; Lefeber DJ; ; Lin YY; Muntoni F
    Am J Hum Genet; 2013 Jul; 93(1):29-41. PubMed ID: 23768512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phosphoinositide 5-phosphatase INPP5K: From gene structure to in vivo functions.
    Schurmans S; Vande Catsyne CA; Desmet C; Moës B
    Adv Biol Regul; 2021 Jan; 79():100760. PubMed ID: 33060052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B3GALNT2 mutations associated with non-syndromic autosomal recessive intellectual disability reveal a lack of genotype-phenotype associations in the muscular dystrophy-dystroglycanopathies.
    Maroofian R; Riemersma M; Jae LT; Zhianabed N; Willemsen MH; Wissink-Lindhout WM; Willemsen MA; de Brouwer APM; Mehrjardi MYV; Ashrafi MR; Kusters B; Kleefstra T; Jamshidi Y; Nasseri M; Pfundt R; Brummelkamp TR; Abbaszadegan MR; Lefeber DJ; van Bokhoven H
    Genome Med; 2017 Dec; 9(1):118. PubMed ID: 29273094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recessive TRAPPC11 mutations cause a disease spectrum of limb girdle muscular dystrophy and myopathy with movement disorder and intellectual disability.
    Bögershausen N; Shahrzad N; Chong JX; von Kleist-Retzow JC; Stanga D; Li Y; Bernier FP; Loucks CM; Wirth R; Puffenberger EG; Hegele RA; Schreml J; Lapointe G; Keupp K; Brett CL; Anderson R; Hahn A; Innes AM; Suchowersky O; Mets MB; Nürnberg G; McLeod DR; Thiele H; Waggoner D; Altmüller J; Boycott KM; Schoser B; Nürnberg P; Ober C; Heller R; Parboosingh JS; Wollnik B; Sacher M; Lamont RE
    Am J Hum Genet; 2013 Jul; 93(1):181-90. PubMed ID: 23830518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy.
    Godfrey C; Escolar D; Brockington M; Clement EM; Mein R; Jimenez-Mallebrera C; Torelli S; Feng L; Brown SC; Sewry CA; Rutherford M; Shapira Y; Abbs S; Muntoni F
    Ann Neurol; 2006 Nov; 60(5):603-610. PubMed ID: 17044012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. POMK mutations disrupt muscle development leading to a spectrum of neuromuscular presentations.
    Di Costanzo S; Balasubramanian A; Pond HL; Rozkalne A; Pantaleoni C; Saredi S; Gupta VA; Sunu CM; Yu TW; Kang PB; Salih MA; Mora M; Gussoni E; Walsh CA; Manzini MC
    Hum Mol Genet; 2014 Nov; 23(21):5781-92. PubMed ID: 24925318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fourth case of POMT2-related limb girdle muscle dystrophy with mild reduction of α-dystroglycan glycosylation.
    Saredi S; Gibertini S; Ardissone A; Fusco I; Zanotti S; Blasevich F; Morandi L; Moroni I; Mora M
    Eur J Paediatr Neurol; 2014 May; 18(3):404-8. PubMed ID: 24183756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy.
    Larson AA; Baker PR; Milev MP; Press CA; Sokol RJ; Cox MO; Lekostaj JK; Stence AA; Bossler AD; Mueller JM; Prematilake K; Tadjo TF; Williams CA; Sacher M; Moore SA
    Skelet Muscle; 2018 May; 8(1):17. PubMed ID: 29855340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
    Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
    Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.